Pharmacoeconomic fellowship programmes have been in existence for more than 10 years, but their effectiveness has not been evaluated. The aim of this project was to construct a framework to examine the potential outcome measures for pharmacoeconomic fellowships so that the effectiveness of these programmes may be determined. Using the Donabedian model, the structures, processes, and outcomes of pharmacoeconomic fellowship programmes were investigated. The structures of these programmes include the facilities, qualifications of the teaching staff and organisation, and operations of the institution. Most pharmacoeconomic fellowships are based in academic institutions and the pharmaceutical industry. Credentials of the preceptors and teaching staff consist of an advanced degree and relevant expertise in pharmacoeconomics and outcomes research. The processes of pharmacoeconomic fellowships include the duration of the programme as well as the research skills and the educational components taught. However, current guidelines do not define outcome measures for these pharmacoeconomic fellowships. Potential outcomes may include whether or not a degree was obtained, the management and research skills acquired, as well as the type of experiential training received. Further research is required to develop these outcome measures, so the effectiveness of pharmacoeconomic fellowship programmes may be assessed.
KeywordsFellowship Programme Research Skill Advanced Degree Educational Component Pharmacoeconomic Research
We greatly appreciate the assistance of the following people: Lisa E. Paddock, MPH; Jennifer Koenig, MS; Anne Mooney.
- 1.Pritchard C. Trends in economic evaluation: OHE briefing No. 36. London, England. Office of Health Economics, 1998Google Scholar
- 4.Motheral BR, Grizzle AJ, Armstrong EP, et al. Role of pharmacoeconomics on drug benefit decision-making: results of a survey. Formulary May 2000; 35: 412–21Google Scholar
- 7.Gregor KJ, Draugalis JR. Graduate pharmacoeconomic education and training programs in US colleges of pharmacy. Am J Pharm Educ 1994; 58: 378–81Google Scholar
- 8.Cooke J, Godman B, Giles-Burness D. Pharmacoeconomics teaching in the North West Region. Pharm J 1994; 252: 864–6Google Scholar
- 11.American College of Clinical Pharmacy, editor. Directory of Residencies and Fellowships 2000. Kansas City, (MO): American College of Clinical Pharmacy, 2000Google Scholar
- 12.American Society of Health-System Pharmacists. Definitions of pharmacy residencies and fellowships. Am J Hosp Pharm 1987; 44: 1142–4Google Scholar
- 24.Pharmacoeconomic and Outcomes Research Fellowship Standards. The Office of Health Policy and Clinical Outcomes, Thomas Jefferson University. Jun 2000: 8 (Data on file)Google Scholar
- 25.Standards for fellowship training in pharmacoeconomics and outcomes research. ISPOR position statement. May 1998: 6 (Data on file)Google Scholar
- 26.What do you consider an ideal training for the practitioner of pharmacoeconomi c research? ISPOR News Jan–Feb 1999; 5 (1): 4–6. Available from: URL: http://www.ispor.org/news/0501/ifits.html [Accessed 2000 Jul 12]
- 30.Lloyd KB, Lee JT, Strassels S. The relative effects of fellowship training on career path, job satisfaction and burnout, and quality of life. Pharmacotherapy 1998; 28: 430Google Scholar
- 31.Kohn LT, Corrigan JM, Donaldson MS, editors. To err is human: building a safer health system. Committee on Quality of Healthcare in America, Institute of Medicine. Washington DC: National Academy Press, 2000Google Scholar